BioAmber Inc.
BIOA
BIOA was delisted on the 8th of February, 2018.
32 hedge funds and large institutions have $72.6M invested in BioAmber Inc. in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 5 closing their positions.
74,500% more call options, than puts
Call options by funds: $746K | Put options by funds: $1K
200% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 4
48% more capital invested
Capital invested by funds: $48.9M → $72.6M (+$23.7M)
3% less funds holding
Funds holding: 33 → 32 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.39M |
| 2 |
RS
Robeco Schweiz
Zurich,
Switzerland
|
+$1.92M |
| 3 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$483K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$361K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$204K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$663K |
| 2 |
Renaissance Technologies
New York
|
-$239K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$116K |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$85K |
| 5 |
Goldman Sachs
New York
|
-$47K |
BIOA Hedge Fund Activity: Q4 2016 in Review
32 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q4 2016, worth a combined $72.6M — up 48% from $48.9M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BIOA and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 12 added.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $5.39M. The largest seller was Waddell & Reed Financial, cutting an estimated $663K.
- 32 institutional investors held BioAmber Inc. (BIOA) as of Q4 2016, down from 33 in Q3 2016.
- Funds reported $72.6M of BioAmber Inc. stock for Q4 2016, up 48% quarter-over-quarter.
- 4 funds opened new BioAmber Inc. positions in Q4 2016 and 5 closed out, a net change of -1 holder.
- The largest BioAmber Inc. buyer in Q4 2016 was Fidelity Investments, an estimated $5.39M added.
- The largest BioAmber Inc. seller in Q4 2016 was Waddell & Reed Financial, an estimated $663K sold.
Based on aggregated 13F filings for Q4 2016.